Northern Colorado Surgeon Releases Three Year Results of Bone Marrow Stem Cell Treatment

Share Article

Dr. Kenneth Pettine, retired orthopedic spine surgeon and co-founder of Elite Regenerative Stem Cell Specialists, has released results of a study he performed using bone marrow concentrate stem cell injections on patients with degenerative disc disease causing severe chronic low back pain. The results found that three to five years after treatment, the patients reported on average 70% improvements in their low back pain and activity levels without surgery and no adverse side effects.

News Image
This study provides the first long term evidence of the safety and feasibility of utilizing a patient's own bone marrow concentrate stem cells to treat severe low back pain

Retired orthopedic spine surgeon, Kenneth Pettine, M.D. is excited to release the three year results of his bone marrow stem cell treatment study. Dr. Pettine has been a pioneer in the use of bone marrow concentrate stem cell injections. He was the first surgeon to inject biologics into the human spine as part of an FDA Study in the U.S. almost seven years ago. He has the only U.S. Patent on the method of treating orthopedic and spine pathology with a patient's own stem cells.

“This study provides the first long term evidence of the safety and feasibility of utilizing a patient's own bone marrow concentrate stem cells to treat severe low back pain,” said Dr. Pettine. “That’s terrific news for patients who up until now only had the option of undergoing expensive and invasive back fusion or artificial disc surgery.”

Degenerative disc disease is a common back pain diagnosis in the United States and affects millions of patients. The symptoms of the condition can become so painful that patients may be forced to miss work and are prevented from participating in regular daily activities. Treatment is often limited to palliative care such as chiropractic, physical therapy, narcotics, injections or invasive surgical procedures to try to decrease the daily chronic low back pain. Numerous studies have shown surgery improves back pain in the average patient only 40%. Stem Cell therapy improved the average patient 70% with long term follow up.

Dr. Pettine’s treatment uses a patient's own bone marrow concentrate stem cells to help reduce inflammation in the spine and stimulate the creation of new tissue in the spinal disc to help reverse the effects of the disease. The office procedure is performed with I.V. sedation and usually takes 45 minutes. The study noted that patients who received higher concentrations of stem cells in their injections saw a greater improvement in their back pain.. This three year follow-up research study shows utilizing a patient's own stem cells can provide long-term back pain relief and prevented the need for invasive surgery in 77% of the patients.

If you live in the Northern Colorado area and are experiencing neck or back pain due to degenerative disc disease, you can learn more about Dr. Pettine’s treatment and research by visiting his website at http://www.KennethPettine.com.

About Dr. Kenneth Pettine
Dr. Pettine has been the principal investigator of 18 FDA studies about stem cells and their uses and is considered a pioneer in the field. He founded The Rocky Mountain Associates in Orthopedic Medicine in 1991 to offer patients a non-fusion surgical option for their neck and back pain. He co-invented the FDA-approved Prestige™ cervical artificial disc and the Maverick Artificial Disc™. He is currently focused on the use of Mesenchymal stem cell therapy for patients desiring to avoid orthopedic or spine surgery. You can learn more about the therapy and Dr. Pettine at his website, http://www.KennethPettine.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Farra Larimore for Dr. Kenneth Pettine
Kenneth Pettine, M.D.
+1 (970) 541-3284 Ext: 3284
Email >
Visit website

Media